Aprea Therapeutics, Inc. (APRE)
Cost of Revenue
$5.43K
TTM · Period ending: · USD
APRE Cost of Revenue
Latest reported$5.43Kperiod ending
Latest reported$5.43Kperiod ending
APRE Cost of Revenue ($7.93K → $5.43K)
Annual cost of revenue
High-resolution chart · PNG
APRE cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 9,363,537 | |
| 7,052 | |
| 16,402,273 | |
| 271,677 | |
| 229,610 | |
| 170,254 | |
| 8,316 | |
| 7,932 |